Concepedia

Megumi Inaba

MI

Statistics

Publications

10

Citations

310

H-Index

10

Active since

2011

Affiliations

Saiseikai Kumamoto Hospital(Current)

Kumamoto University Hospital

Kumamoto Medical Center

Japan Organization of Occupational Health and Safety

Chiba University

Megumi Inaba is an author at Saiseikai Kumamoto Hospital specializing in non-small cell lung cancer treatment, pharmacology, and lung cancer.

Publications per year

2011–2023

10

Publications

10

Osimertinib as first-line treatment for advanced epidermal growth factor receptor mutation–positive non–small-cell lung cancer in a real-world setting (OSI-FACT)

Yoshihiko Sakata, Shinya Sakata, Yuko Oya et al. · European Journal of Cancer · 2021 · 89 citations

, , +12

Protective effect of bevacizumab on chemotherapy-related acute exacerbation of interstitial lung disease in patients with advanced non-squamous non-small cell lung cancer

Shohei Hamada, Hidenori Ichiyasu, Tokunori Ikeda et al. · BMC Pulmonary Medicine · 2019 · 61 citations · Full text

, , +13

Drug-Related Pneumonitis Induced by Osimertinib as First-Line Treatment for Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer

Yuki Sato, Hiromitsu Sumikawa, Ryota Shibaki et al. · CHEST Journal · 2022 · 40 citations

, , +12

Association of <i>ABCB1</i> Polymorphisms with Erlotinib Pharmacokinetics and Toxicity in Japanese Patients with Non-Small-Cell Lung Cancer

Akinobu Hamada, Ji-ichiro Sasaki, Sho Saeki et al. · Pharmacogenomics · 2012 · 26 citations

, , +15

Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study

Mihoko Imaji, Daichi Fujimoto, Yuki Sato et al. · European Journal of Cancer · 2022 · 22 citations

, , +6

1–5 of 10